Value-based arrangements (VBA) are increasingly used, although most medicines are paid based on volume of product purchased or cost per unit. Lilly believes the price of medicines should be linked more directly to patient outcomes. In a partnership with Prime Therapeutics, the organizations […]
Going on Now! AcademyHealth 2020 is Virtual Yet Vital: Here’s Why
Kicking off today, AcademyHealth 2020 will provide vital insights over a 2-week period from July 28 – August 6 with both live and on-demand sessions. Sessions include AHRQ updates from Director Gopal Khanna, Princeton University professor Dr. Ruha Benjamin on Race, Research and the Power and Peril […]
Showdown: White House Cancels Pharma Meeting on International Pricing
On Tuesday, July 28, the White House abruptly canceled a meeting with drug company executives to discuss the most favored nation executive order, with a focus on the upcoming executive order to direct Medicare to tie Part B drug reimbursement to international prices. A White House spokesperson […]
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018
Kim et. al. of Tufts Medical Center published an examination in the journal Pharmacoeconomics assessing CEA and Global Health CEA registries, containing 6907 cost-per-quality-adjusted-life-year (QALY) and 698 cost-per-disability-adjusted-life-year (DALY) studies published through 2018. Researchers […]
ISPOR Offering Course on Causal Inference in Observational, Pragmatic Trials
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering a 4-hour course on causal inference in observational data and pragmatic trials. The advanced course is set to begin 10 a.m. EST July 30. "This course will provide an introduction to the principles of […]
IFAPP, MAPS Course Offers Certificate in Medicine Development
An online course hosted by IFAPP Academy in partnership with the Medical Affairs Professional Society (MAPS) aims to give medical affairs experts greater insight into the drug development pipeline. The application for the course, which runs Sept. 7 through Dec. 4, is due by Sept. 1. "If you’re […]
Rho Experts to Explore Decentralized Trials
Rho's Rob Woolson and Derek Lawrence will discuss in an upcoming webinar how the company is helping trial sponsors get the most out of decentralized trials. Woolson is Rho's chief strategist of biostatistics and standards for regulatory submissions, and Derek Lawrence is the associate director of […]
Former FDA Chief Talks Value-Based Care, Medical Tech
In a new Patients Rising podcast, former FDA Chief Mark McClellan explores how the COVID-19 pandemic has revealed the benefits of value-based care and medical technology. McClellan led the FDA from 2002-2004, after which served as administrator of the Centers for Medicare and Medicaid Services […]
ISPOR Webinar on Leadership Skills Nears
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) "Pathways to ISPOR Leadership" webinar is right around the corner. Registration for the Aug. 4 webinar remains open. The online event is set to begin 10 a.m. EST. "The webinar series was developed to provide […]
NPC: CMS Proposed Rule Hinders Value-Based Arrangements
In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues with the agency's recently-proposed rule. NPC says the proposal "poses a barrier to implementing value-based arrangements and hinders innovation in payment and […]
Biotech Company Looks to Create Cheaper Alternatives to Pfizer, AstraZeneca Drugs
EQRX, a private biotech company launched in January, is looking to create cheaper alternatives to Pfizer's Ibrance and AstraZeneca's Tagrisso, according to an Evaluate report. According to the report, EQRX has licensed two projects to bring its plan to fruition: G1's lerociclib and Jiangsu […]
Shulkin: COVID-19 Laying Foundation for ‘Tsunami of Challenges’ for Health System
David Shulkin, former secretary of the Department of Veterans Affairs, says the COVID-19 crisis is ultimately generating a "tsunami of challenges for the health system." In a recent guest piece published on Healthcare Dive, Shulkin points to key long-term issues, including Medicaid […]
Analysis Suggests 80% of New RA, MS Patients Face Utilization Management Restrictions
Roughly 80 percent of commercially-insured patients face utilization management restrictions when attempting to fill a new prescription for rheumatoid arthritis (RA) or multiple sclerosis (MS), IQVIA suggests in a new analysis. IQVIA's analysis includes analytics commissioned by Pharmaceutical […]
NAMCP Looks to Streamline Sharing of Value Propositions
The National Association of Managed Care Physicians' Value Based Care Council says its newly-developed short form streamlines how value propositions are shared between key stakeholders. "[The Product Value Proposition Customer Engagement Short Form] provides a concise and consistent manner with […]
Paper Looks at Impact of Coverage Policies on Pharma Incentives
A recently-published study by Leila Agha, Soomi Kim and Danielle Li analyzes how insurance coverage policies impact incentives for innovation in the pharmaceutical industry. The study suggests the decision by pharmacy benefit managers in 2012 to adopt "closed formularies" resulted in some […]
Article: Drug Pricing Back in Spotlight
With the race for COVID-19 treatments and a vaccine well under way, the issue of drug pricing is again front and center, BioPharm International reports. As uncertainty swirls around Pfizer and AstraZeneca's pledge to offer COVID-19 treatments at no profit, according to the report, some […]
MAPS Appoints Pracyk as President
The Medical Affairs Professional Society (MAPS) appointed its new president of the Americas region, John Pracyk. MAPS in an announcement says Pracyk "brings to the MAPS organization a wealth of experience." "We are honored to include John in this highly visible leadership role, where he is […]
ICER Posts Evidence Report on Obeticholic Acid for NASH
The Institute for Clinical and Economic Review (ICER) on Monday, July 21, posted an evidence report on Intercept Pharmaceuticals' obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH). ICER CMO David Rind in a statement said the review concluded there was much […]
Article Spotlights Virtual Component of ADAPTABLE Study
A recent Clinical Leader article spotlights how the ADAPTABLE study, which was launched in 2016 by PCORI and the Duke Clinical Research Institute, included virtual visits with patients. "We liked the idea of approaching patients to participate in research studies where they live instead of […]
IQVIA’s Dreyer Stresses Importance of RWE Amid Pandemic
In a recent interview with Managed Healthcare Executive, IQVIA CSO Nancy Dreyer said the COVID-19 pandemic has made the use of real-world evidence all the more urgent. Dreyer said the idea of using RWE to create a common external control arm is "one of the biggest opportunities we can't […]
Report Spotlights NPC’s Webinar on COVID-19 Prices
A recent report by The Pink Sheet spotlights the National Pharmaceutical Council's (NPC) recent meeting on COVID-19 drug prices. The webinar was held July 14, and included insights from: Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer […]
NPC Spotlights New NPC/Duke-Margolis Health Policy Fellow Salama Freed
A recent National Pharmaceutical Council blog post spotlights Salama Freed, the new NPC/Duke-Margolis Postdoctoral Health Policy fellow. Freed says she believes the fellowship will help bolster her understanding of health policy. "I want this research to actually turn into something," she […]
Roche, Genentech Enter into RWD Deal with PicnicHealth
Roche and Genentech have entered into an agreement with PicnicHealth, a San Francisco-based startup, to generate new insights into certain diseases, according to a MobiHealthNews report. According to the report, the agreement will initially focus on multiple sclerosis, but could in the future […]
Aetion, Cegedim Partnership Looks to Bring Together RWD, Clinical Trial Tech
A new partnership between Aetion and Cegedim Health Data looks to integrate real-world data compiled from European sources into clinical trial technology, Outsourcing Pharma reports. The collaboration involves Cegedim's The Health Improvement Network (THIN) database and the Aetion Evidence […]
Blog Post: ‘Diverse Initiatives’ Necessary to Bolster Condition-Based Payment Models
While condition-based payment models have the potential to facilitate "specialist-driven value-based care," a number of key hurdles remain, the authors of a recent Health Affairs Blog post write. "Diverse initiatives will be needed in the coming years to expand new model designs to a wider range […]
First Installment in ICER Webinar Series is Friday
The first session of the Institute for Clinical and Economic Review's (ICER) upcoming webinar series is set for Friday, July 24. ICER is hosting a 3-part colloquium series to complement its recent white paper on alternative approaches for pricing COVID-19 treatments and vaccines. The first […]
MAPS, phactMI Partner on New Medical Information Working Group
The Medical Affairs Professional Society (MAPS) and phactMI are partnering on a new medical information working group. According to MAPS, the Medical Information Focus Area Working Group (FAWG) will focus on "leveraging the expertise and experience of the global medical information […]
Elligo Launches Expanded SOAR Model
Elligo Health Research announced the launch of its expanded System of Accelerated Research (SOAR) model for decentralized and hybrid trial models. According to a press release, the platform offers full remote monitoring. "We are extremely excited to launch our tech-enabled solution created to […]
Companies Ramping Up Digital Transformation Plans as Result of COVID-19, Survey Finds
A recent survey by Twilio suggests that a clear majority of companies have sped up their digital transformation plans in response to the COVID-19 pandemic. "Decade-long digital transformation roadmaps got compressed into days and weeks in order to respond to the realities of shelter in place," […]
Gao: ‘Misunderstanding of P-values Spells Disaster’
A greater understanding of the p-value could go a long way in trying to combat contradictory health advice, Jian Gao with the Department of Veterans Affairs writes in a post on The Incidental Economist. Gao writes that the tool which is generally used as a safeguard against randomness "has been […]
